SCYX
Scynexis Inc
NASDAQ: SCYX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.93
-0.46% today
Updated 2026-04-30
Market cap
$78.31M
P/E ratio
—
P/S ratio
3.80x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$1 – $1
Volume
0.6M
Scynexis Inc (SCYX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-10.60M | $-4.31M | $-9.47M | $-24.55M | $-29.35M | $-24.56M | $-28.32M | $-38.12M | $-49.35M | $-54.56M | $-79.88M | $60.16M | $-24.01M | $-5.28M |
| Capital expenditures | $361000.00 | $431000.00 | $704000.00 | $589000.00 | $27000.00 | $2000.00 | $565000.00 | $4000.00 | $4000.00 | $1.17M | $9000.00 | $60.16M | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $358000.00 | $180000.00 | $1.20M | $3.02M | $1.21M | $1.66M | $1.82M | $1.83M | $2.22M | $2.09M | $3.69M | $2.62M | $3.35M | $2.85M |
| Free cash flow | $-10.96M | $-4.74M | $-10.18M | $-25.13M | $-29.38M | $-24.56M | $-28.89M | $-38.12M | $-49.36M | $-55.73M | $-79.89M | $0.00 | $-24.01M | $-5.28M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | $10.03M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $30.84M | $14.74M | $-11.33M | $-24.19M | $298000.00 | $30.43M | $51.12M | $11.39M | — | — | — | — |